评估对罗马IV标准用于肠易激综合征诊断的修改后的诊断性能
本文评估对罗马IV肠易激综合征诊断标准的修改能否在敏感性与特异性之间取得更好平衡。罗马IV较罗马III更严格,因将必备特征改为仅腹痛并将腹痛频率提高至每周1天,导致社区患病率下降50%,在罗马III定义但不符合罗马IV的IBS人群中89%因疼痛频率改变而未满足罗马IV。既往罗马标准预测IBS诊断表现一般,但一项验证研究中罗马IV优于罗马III,主要因其更严格而更具特异性。
要点
- 罗马IV较罗马III更严格,腹痛频率要求从每月2至3天提高至每周1天。
- 该修改使IBS社区患病率下降50%,并降低检测IBS的敏感性。
- 罗马III定义但不符合罗马IV的IBS人群中89%因疼痛频率改变而未满足罗马IV。
核心结论
- 评估对罗马IV标准的修改能否在敏感性与特异性之间取得更好平衡。
研究设计与样本
- 原文未报告研究设计与样本。
主要发现
- 罗马IV较罗马III更严格,因必备特征改为仅腹痛且腹痛频率提高至每周1天。
- 该修改导致检测IBS的敏感性降低,社区患病率下降50%。
- 在同时应用罗马IV和III标准的横断面调查中,罗马III定义但不符合罗马IV的IBS人群89%因疼痛频率改变而未满足罗马IV。
- 既往罗马标准预测IBS诊断表现一般,但一项验证研究中罗马IV优于罗马III,主要因其更严格而更具特异性。
关键数值与推荐
- 罗马IV要求腹痛频率为每周1天,罗马III为每月2至3天。
- 罗马IV较罗马III更严格,社区IBS患病率下降50%。
- 罗马III定义但不符合罗马IV的IBS人群中89%因疼痛频率改变而未满足罗马IV。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The gold standard symptom-based criteria for diagnosis of irritable bowel syndrome (IBS) are the Rome IV criteria.1 These are more restrictive than their predecessor, Rome III, because the cardinal feature required to meet criteria for IBS was changed to presence of abdominal pain alone, rather than abdominal pain or discomfort.2 This change was made because discomfort was believed to be an ambiguous term, with no equivalent in some languages. In addition, symptom frequency required for the presence of abdominal pain was increased to 1 day per week from 2 to 3 days per month. This has led to reduced sensitivity for detecting IBS and a 50% decrease in the prevalence of the disorder in the community.3,4 In a cross-sectional survey applying both Rome IV and III criteria to people living with IBS, 89% of those with Rome III-defined IBS not meeting Rome IV criteria did not meet Rome IV criteria because of this change in pain frequency.5 Previous iterations of the Rome criteria have performed only modestly in predicting a diagnosis of IBS.6-8 However, in a validation study, the Rome IV criteria outperformed Rome III,9 largely because their more restrictive nature made them more specific than Rome III. We assessed whether modifications to the Rome IV criteria led to a better trade-off between sensitivity and specificity.
引用
- Goodoory VC, Khasawneh M, Black CJ, et al. Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2024. PMID: 38423348. doi:10.1016/j.cgh.2024.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。